UK markets closed
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • FTSE 250

    23,658.94
    +26.10 (+0.11%)
     
  • AIM

    1,275.74
    +3.60 (+0.28%)
     
  • GBP/EUR

    1.1711
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.3737
    -0.0059 (-0.43%)
     
  • BTC-GBP

    34,629.13
    -802.79 (-2.27%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • DOW

    34,584.88
    -166.44 (-0.48%)
     
  • CRUDE OIL

    71.96
    -0.65 (-0.90%)
     
  • GOLD FUTURES

    1,753.90
    -2.80 (-0.16%)
     
  • NIKKEI 225

    30,500.05
    +176.71 (+0.58%)
     
  • HANG SENG

    24,920.76
    +252.91 (+1.03%)
     
  • DAX

    15,490.17
    -161.58 (-1.03%)
     
  • CAC 40

    6,570.19
    -52.40 (-0.79%)
     

Global $3.5+ Bn microRNA (miRNA) Markets Analysis & Forecasts, 2016-2020 & 2021-2028

Dublin, Aug. 17, 2021 (GLOBE NEWSWIRE) -- The "microRNA Market Share, Size, Trends, Industry Analysis Report, By Product; By Services; By Application; By End-Use; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The global microRNA market size is expected to reach USD 3.51 billion by 2028

The rising adoption of microRNA as a biomarker is driving the market. These biomarkers are particularly important in genome-wide population studies, data-driven methods, as they have the ability to demonstrate high robustness and reproducibility, as compared to traditional procedures. Hence, such molecules serve as a promising drug candidate to develop biomarkers. Moreover, growing interest in liquid-based biopsies has further led to its increased importance in biomarker discovery and further development.

Continuous rise in research activities has also explored the potential of microRNA biomarkers across prognosis, therapeutics, and diagnosis to favor the market expansion in near future. In this direction, in January 2020, research scholars have explored the presence of microRNA in the peripheral blood vessel as a biomarker to diagnose bipolar II disorder using NGS. These microRNAs could serve as a possible non-invasive solution to diagnose any indication of neurodegenerative disorders.

The cardiovascular segment is projected to witness a lucrative market growth rate over the assessment period. This is primarily due to the introduction of novel biomarkers for early diagnosis of heart-related ailments, and significant investments in the sector.

microRNAs are presumed to be an attractive option for cardiovascular therapeutics due to their several benefits such as tissue-specific expressions, secretion of body fluids, and stability. Moreover, many studies gave also pointed to the role of microRNAs in the regulation of lipoprotein metabolism, hypertension, blood pressure, and even progression of adjacent co-morbidities.

Asia Pacific market is projected to witness a lucrative growth rate over the microRNA study period. The growth in the region is primarily due to advancements in genomics and proteomics in genomic studies and the rapid adoption of new tools supporting research goals.

For instance, in March 2021, researchers based in Chinese universities have identified blood microRNA as a potential biomarker for hepatic sinusoidal obstruction syndrome via microarray-based profiling. In addition, a market study has also paved several computational tools to predict the relation between miRNA and its target microRNA.

Market participants operating in the microRNA industry include

  • Merck KgaA

  • Thermo Fisher

  • BioGenex

  • New England Biolabs

  • Horizon Discovery

  • GeneCopoeia

  • Quantabio

  • NanoString

  • SeqMatic LLC

  • Sistemic Scotland Limited

  • Synlogic

  • QIAGEN

  • Miltenyi Biotec

  • Biodynamics Laboratory Inc.

  • OriGene Technologies.

Key Topics Covered:

1. Introduction

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.2. Data Products

4. microRNA Market Insights
4.1. microRNA - Industry snapshot
4.2. microRNA Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Wide adoption of microRNA tools
4.2.1.2. Disease associated applications
4.2.2. Restraints and Challenges
4.2.2.1. Scalability issues
4.3. Porter's Five Forces Analysis
4.4. PESTLE Analysis
4.5. microRNA Market Industry trends
4.6. COVID-19 Impact Analysis

5. microRNA Market Assessment by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global microRNA Market, By Product, 2016 - 2028 (USD Million)
5.3. Instruments
5.4. Consumables

6. Global microRNA Market, by Services
6.1. Key Findings
6.2. Introduction
6.2.1. Global microRNA Market, By Service Type, 2016 - 2028 (USD Million)
6.3. Service Type
6.3.1. Global microRNA Market, by Powder, By Region, 2016- 2028 (USD Million)
6.3.2. Isolation & Purification
6.3.3. miRNA cDNA Synthesis
6.3.4. Profiling, Localization, & Quantification
6.3.5. Functional Analysis
6.4. Specimen
6.4.1. Global microRNA Market, by Specimen, by Region, 2016- 2028 (USD Million)
6.4.2. Whole Blood
6.4.3. Serum
6.4.4. Plasma
6.4.5. FFPE
6.4.6. Fresh Frozen Tissue

7. Global microRNA Market, by End Use
7.1. Key Findings
7.2. Introduction
7.2.1. Global microRNA Market, By End Use, 2016 - 2028 (USD Million)
7.3. Biotechnology & Pharmaceutical Companies
7.4. Academic & Government Research Institutes

8. microRNA Market Assessment by Application
8.1. Key Findings
8.2. Introduction
8.2.1. Global microRNA Market, By Application, 2016 - 2028 (USD Million)
8.3. Cancer
8.4. Infectious Diseases
8.5. Immunological Disorder
8.6. Cardiovascular Disease
8.7. Neurological Disease

9. microRNA Market Assessment by Geography
9.1. Key findings
9.2. Introduction
9.2.1. microRNA Market Assessment, By Geography, 2016- 2028 (USD Million)

10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles
11.1. Company Overview
11.2. Financial Performance
11.3. Product & Services Benchmarking
11.4. Recent Development

For more information about this report visit https://www.researchandmarkets.com/r/1lmv7y

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting